首页|分化型甲状腺癌患者术后再次131I治疗疗效的影响因素分析

分化型甲状腺癌患者术后再次131I治疗疗效的影响因素分析

扫码查看
目的 探讨分化型甲状腺癌(differentiated thyroid cancer,DTC)患者的临床指标(肿瘤大小和多灶性)、术后首次131I治疗前刺激性甲状腺球蛋白(preablative stimulated thyroglobulin,ps-Tg)水平、刺激性甲状腺球蛋白(stimulated thyroglobulin,s-Tg)水平以及s-Tg/抑制性甲状腺球蛋白(supressed thyroglobulin,sup-Tg)的比值对DTC患者再次131I治疗疗效不佳的预测价值.方法 选取2017年6月至2021年1月在徐州医科大学附属医院行甲状腺全切术并行再次131I治疗的DTC患者162例.根据《131 I治疗分化型甲状腺癌指南(2021)版》将患者分为疗效满意(excellent response,ER)组、疗效不确切(indeterminate response,IDR)组、生化疗效不佳(biochemical incomplete response,BIR)组和结构性疗效不佳(structural incomplete response,SIR)组,比较不同疗效分组临床特征(年龄、性别、肿瘤最大径和肿瘤多灶性等)和血清学指标(ps-Tg水平、s-Tg水平和s-Tg/sup-Tg比值)等的差异.ER组和IDR组为治疗效果满意组,BIR组和SIR组为疗效不佳组.绘制受试者工作特征(receiver operating characteristic,ROC)曲线分析ps-Tg水平、s-Tg水平和s-Tg/sup-Tg比值预测DTC患者再次131I治疗疗效不佳的诊断价值.结果 DTC患者的性别、年龄、肿瘤多灶性、肿瘤大小和首次131I治疗剂量/131I治疗总剂量的比值均不是再次131I治疗疗效的影响因素(均P>0.05).ER组、IDR组、BIR组和SIR组血清学指标ps-Tg水平、s-Tg水平和s-Tg/sup-Tg比值比较,差异均具有统计学意义(均P<0.05).ps-Tg水平、s-Tg水平和s-Tg/sup-Tg比值预测DTC患者再次131I治疗疗效不佳的ROC曲线下面积分别为0.825、0.941和0.809,最佳诊断界值分别为21.24 μg/L、8.42 μg/L及7.87,约登指数分别为0.570、0.770和0.509,敏感度分别为76.2%、95.2%和 76.2%,特异度分别为80.8%、82.8%和74.7%.结论 ps-Tg水平、s-Tg水平和s-Tg/sup-Tg比值对DTC患者再次131I治疗疗效有一定的预测价值.
Influencing factors of therapeutic effects of 131I re-ablation treatment on differentiated thyroid cancer
Objective To explore the predictive value of the clinical indicators including tumor size and tumor multifocality,preab-lative stimulated thyroglobulin(ps-Tg)level before the initial 131I ablation,stimulated thyroglobulin(s-Tg)level,and s-Tg/supressed thyroglobulin(sup-Tg)of differentiated thyroid cancer(DTC)patients for poor curative effect of 131I re-ablation.Methods A total of 162 DTC patients who underwent total thyroidectomy and retreatment with 131I ablation in the Affiliated Hospital of Xuzhou Medical Univer-sity from June 2017 to January 2021 were selected and divided into excellent response(ER)group,indeterminate response(IDR)group,biochemical incomplete response(BIR)group and structural incomplete response(SIR)group according to the Guidelines for Radioiodine Therapy of Differentiated Thyroid Cancer(2021 edition).The differences in clinical characteristics including age,gender,tumor size,and tumor multifocality,and serological indicators including ps-Tg level,s-Tg level,and s-Tg/sup-Tg were analyzed between the groups.ER and IDR groups were defined as satisfactory curative effect group,and BIR and SIR groups were as poor curative effect group.Receiver operating characteristic(ROC)curves were used to evaluate the values of ps-Tg level,s-Tg level,and s-Tg/sup-Tg for predicting poor curative effect of 131I re-ablation in DTC patients.Results Gender,age,tumor multifocality,tumor size,and the ratio of first 131I dose to total 131 I dose in DTC patients were not the influencing factors for the efficacy of 131 I re-ablation(all P>0.05).The serological indica-tors including ps-Tg,s-Tg,and s-Tg/sup-Tg were significantly different among four groups(all P<0.05).The ROC curves of ps-Tg,s-Tg,and s-Tg/sup-Tg for predicting the poor efficacy of 131I re-ablation in DTC patients showed that the areas under the curves were 0.825,0.941,and 0.809,the best diagnostic cut-off points were 21.24 μg/L,8.42 μg/L,and 7.87,the corresponding Youden indices were 0.570,0.770,and 0.509,the sensitivities were 76.2%,95.2%,and 76.2%,and the specificities were 80.8%,82.8%,and 74.7%,respectively.Conclusions ps-Tg level,s-Tg level,and s-Tg/sup-Tg have certain predictive value for the efficacy of 131I re-ablation in DTC patients.

differentiated thyroid cancerthyroglobuliniodine radioisotoperadiation therapy

郭卫、李智勇、朱辉、朱远、陆园

展开 >

徐州医科大学附属医院核医学科,江苏徐州 221000

分化型甲状腺癌 甲状腺球蛋白 碘放射性核素 放射疗法

2024

实用肿瘤杂志
浙江大学

实用肿瘤杂志

CSTPCD
影响因子:1.034
ISSN:1001-1692
年,卷(期):2024.39(3)
  • 19